| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.42 | 0.03 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |